Enrolment in rTMS sessions plus Text4Support for Depressive Disorder, Treatment-Resistant

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Depressive Disorder, Treatment-Resistant+2 More
Repetitive Transcranial Magnetic Stimulation (rTMS) Plus Text4Support - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether combining rTMS sessions with Text4Support is more effective than rTMS sessions alone in treating mental illness.

Eligible Conditions
  • Depressive Disorder, Treatment-Resistant

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 6 months

6 months
Columbia Suicide Severity Rating Scale
Mental Depression
Mental Depression
The World Health Organization - Five Well-Being Index (WHO-5)
World Health Organization Disability Assessment 2.0

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Enrolment in rTMS sessions alone
1 of 2
Enrolment in rTMS sessions plus Text4Support
1 of 2
Active Control
Experimental Treatment

200 Total Participants · 2 Treatment Groups

Primary Treatment: Enrolment in rTMS sessions plus Text4Support · No Placebo Group · N/A

Enrolment in rTMS sessions plus Text4Support
Device
Experimental Group · 1 Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) Plus Text4Support · Intervention Types: Device
Enrolment in rTMS sessions alone
Device
ActiveComparator Group · 1 Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

University of AlbertaLead Sponsor
805 Previous Clinical Trials
369,433 Total Patients Enrolled
2 Trials studying Depressive Disorder, Treatment-Resistant
140 Patients Enrolled for Depressive Disorder, Treatment-Resistant
Vincent Agyapong, MD, Ph.DPrincipal InvestigatorDivision of Community Psychiatry, University of Alberta

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 12th, 2021

Last Reviewed: October 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Alberta100.0%
How old are they?
65+100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
References